Literature DB >> 15682362

Can the reversible regional wall motion abnormalities on stress gated Tc-99m sestamibi SPECT predict a future cardiac event?

Nunzia Rosa Petix1, Stelvio Sestini, Gabriella Marcucci, Angela Coppola, Angela Arena, Franco Nassi, Andrea Taiti, Vincenzo Guarnaccia, Alberto Mennuti, Vincenzo Mazzoni.   

Abstract

BACKGROUND: Myocardial stunning has recently been demonstrated by use of stress gated technetium 99m sestamibi single photon emission computed tomography (SPECT) myocardial perfusion scintigraphy. However, its prognostic value is less well determined. The aim of this study was to investigate the prognostic value of reversible regional wall motion abnormalities (RWMAs). METHODS AND
RESULTS: We studied 303 consecutive subjects with known or suspected coronary artery disease who underwent 2-day stress-rest gated Tc-99m sestamibi SPECT and were followed up for 19 +/- 16 months. Clinical and test-derived variables were evaluated to predict cardiac death, nonfatal myocardial infarction (MI), unstable angina, and early or late coronary revascularization. Reversible RWMAs were identified in 102 patients. On Cox analysis, the presence, site, degree, and extent of reversible RWMAs did not identify an adverse outcome, except in patients without prior MI. After adjustment for prescan data, the strongest predictors of hard events and all cardiac events were poststress RWMAs and the amount of ischemia. The addition of poststress RWMAs to the combined model of prescan and perfusion data yielded incremental prognostic value.
CONCLUSION: Poststress RWMAs and ischemia by perfusion were the most powerful predictive parameters of cardiac events. However, myocardial stunning should always be considered, particularly in patients without prior MI and in the referral of patients for early revascularization.

Entities:  

Mesh:

Year:  2005        PMID: 15682362     DOI: 10.1016/j.nuclcard.2004.09.017

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  40 in total

1.  Gated single-photon emission tomography imaging protocol to evaluate myocardial stunning after exercise.

Authors:  J Hashimoto; A Kubo; R Iwasaki; S Iwanaga; H Mitamura; S Ogawa; S Kosuda
Journal:  Eur J Nucl Med       Date:  1999-12

2.  Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease.

Authors:  G Ambrosio; S Betocchi; L Pace; M A Losi; P Perrone-Filardi; A Soricelli; F Piscione; J Taube; F Squame; M Salvatore; J L Weiss; M Chiariello
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

3.  Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. I. Arterographic correlations.

Authors:  A V Bruschke; W L Proudfit; F M Sones
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

4.  Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction.

Authors:  T Sharir; G Germano; X Kang; H C Lewin; R Miranda; I Cohen; R D Agafitei; J D Friedman; D S Berman
Journal:  J Nucl Med       Date:  2001-06       Impact factor: 10.057

5.  A new approach to the assessment of tomographic thallium-201 scintigraphy in patients with left bundle branch block.

Authors:  L Matzer; H Kiat; J D Friedman; K Van Train; J Maddahi; D S Berman
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094

6.  Prognosis by measurements of left ventricular function during exercise. Duke Noninvasive Research Working Group.

Authors:  L J Shaw; S K Heinle; S Borges-Neto; K Kesler; R E Coleman; R H Jones
Journal:  J Nucl Med       Date:  1998-01       Impact factor: 10.057

7.  Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction.

Authors:  D Kroll; W Farah; G R McKendall; S E Reinert; L L Johnson
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

8.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.

Authors:  D S Berman; H Kiat; J D Friedman; F P Wang; K van Train; L Matzer; J Maddahi; G Germano
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

9.  Value of the history and physical in identifying patients at increased risk for coronary artery disease.

Authors:  D B Pryor; L Shaw; C B McCants; K L Lee; D B Mark; F E Harrell; L H Muhlbaier; R M Califf
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

10.  Prognostic value of a coronary artery jeopardy score.

Authors:  R M Califf; H R Phillips; M C Hindman; D B Mark; K L Lee; V S Behar; R A Johnson; D B Pryor; R A Rosati; G S Wagner
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

View more
  18 in total

1.  Role of regional myocardial dysfunction by gated myocardial perfusion SPECT in the prognostic evaluation of patients with coronary artery disease.

Authors:  Tali Sharir
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

Review 2.  Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging.

Authors:  Aiden Abidov; Guido Germano; Rory Hachamovitch; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

3.  Patient preparation for nuclear imaging: when should anti-ischemic medications be withheld?

Authors:  Sarkis B Baghdasarian; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

4.  Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging.

Authors:  Alan W Ahlberg; Sarkis B Baghdasarian; Haris Athar; Jeffrey P Thompsen; Deborah M Katten; Gavin L Noble; Igor Mamkin; Anuj R Shah; Ivette A Leka; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

5.  Better characterization of dipyridamole-induced myocardial stunning by systolic wall thickening. A gated perfusion SPECT study.

Authors:  Alberto Bestetti; Besart Cuko; Massimo Gasparini; Stefano De Servi
Journal:  J Nucl Cardiol       Date:  2018-06-27       Impact factor: 5.952

6.  Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: does it affect diagnosis or prognosis?

Authors:  Talhat Azemi; Mridula Rai; Purvi Parwani; Sarkis Baghdasarian; Fawad Kazi; Alan W Ahlberg; Giselle Cyr; Deborah Katten; David O'Sullivan; Daniel Fram; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2011-09-23       Impact factor: 5.952

7.  Overestimation of postischemic myocardial stunning on gated SPECT imaging: correlation with echocardiography.

Authors:  R Parker Ward; Ethan L Gundeck; Roberto M Lang; Kirk T Spencer; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

8.  Worsening of left ventricular ejection fraction induced by dipyridamole on Tl-201 gated myocardial perfusion imaging predicts significant coronary artery disease.

Authors:  Guang-Uei Hung; Kung-Wei Lee; Ching-Pei Chen; Kuang-Tao Yang; Wan-Yu Lin
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

9.  Additional value of systolic wall thickening in myocardial stunning evaluated by stress-rest gated perfusion SPECT.

Authors:  Alberto Bestetti; Besart Cuko; Adriano Decarli; Alessio Galli; Federico Lombardi
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

10.  Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging.

Authors:  Itsuro Morishima; Takahito Sone; Hideyuki Tsuboi; Hiroaki Mukawa; Michitaka Uesugi; Shuji Morikawa; Kensuke Takagi; Toru Niwa; Yasuhiro Morita; Ryuichiro Murakami; Yasushi Numaguchi; Toyoaki Murohara; Kenji Okumura
Journal:  J Nucl Cardiol       Date:  2008-06-12       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.